MERCK
20.12.2021 14:02:06 CET | Business Wire | Press release
Merck, a leading science and technology company, today announced a strategically focused expansion of its neurology pipeline with the acquisition of the rights to develop cladribine for the treatment of generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Merck entered into an agreement to secure the global rights by acquiring Chord Therapeutics, a Swiss-based biotech company focused on rare neuroinflammatory diseases.
“Cladribine has a unique mechanism of action which is relevant in antibody-mediated disease such as NMOSD and gMG. In exploratory studies, cladribine demonstrated promising results in these diseases. These data have prompted us to initiate further development with cladribine in gMG and NMOSD to potentially bring a new therapeutic option to patients and expand our portfolio in this area,” said Danny Bar-Zohar, MD, Head of Global Development for the biopharma business of Merck.
Cladribine is a well characterized molecule that has been extensively studied across MS and oncologic disorders and has shown promising results in exploratory studies in gMG and NMOSD. Merck plans to leverage its existing capabilities to further develop an oral cladribine product tailored specifically for these indications. The transaction is expected to be closed in early 2022 after satisfactory completion of customary closing conditions.
Generalized myasthenia gravis is a disease in which patients experience weakness in ocular, limb, and respiratory muscles and that has a significant impact on Quality of Life. It is estimated that 700,000 people around the world are living with gMG. NMOSD, also known as Devic´s disease, is an autoimmune disease, often misdiagnosed as MS due to similar symptoms. NMOSD is estimated to impact 200,000 people around the world.
About Chord Therapeutics
Chord Therapeutics is a Swiss-based clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. Chord is advancing its lead drug candidate, CRD1 (cladribine), for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and generalized myasthenia gravis (gMG). Chord Therapeutics was founded in 2014 and launched in October 2020 with Series A funding by its sole investor, Omega Funds, a leading international venture capital firm focused on delivering impactful medicines to patients.
Merck in Neurology and Immunology
Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). The company`s current MS portfolio includes two products for the treatment of relapsing MS – Rebif® (interferon beta-1a) and MAVENCLAD® (cladribine tablets). Merck aims to improve the lives of patients by addressing areas of unmet medical needs. In addition to Merck`s commitment to MS, the company also has a pipeline focusing on discovering new therapies that have the potential in other neuroinflammatory and immune-mediated diseases, including systemic lupus erythematosus (SLE).
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005062/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Uptime Institute and Indonesia Ministry of Communication and Digital Affairs (KOMDIGI) Sign Letter of Intent (LOI) to Support Data Center Policy, Governance, and Industry Development2.11.2026 06:04:00 CET | Press release
Uptime Institute, the Global Digital Infrastructure Authority, and the Ministry of Communication and Digital Affairs (Komdigi) today announced the signing of a Letter of Intent (LOI) to explore collaboration aimed at strengthening Indonesia's data center ecosystem through policy development, governance frameworks, operational excellence, security, sustainability, and workforce capability development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261101628182/en/ Uptime Institute and KOMDIGI sign LOI. The Letter of Intent reflects a shared interest in exploring international best practices that may support the development of reliable, secure, efficient, and sustainable digital infrastructure aligned with Indonesia's national priorities and regulatory framework. The LOI was signed by Mustapha Louni, Chief Business Officer, Uptime Institute, and Wayan Toni Supriyanto, Director General of Digital Infrastructure, Indonesia's Min
Uptime Institute Signs Memorandum of Understanding (MOU) with Indonesian Data Center Providers Association (IDPRO) to Advance Indonesia's Data Center Industry2.11.2026 06:02:00 CET | Press release
Uptime Institute, the Global Digital Infrastructure Authority, today announced the signing of a Memorandum of Understanding (MOU) with the Indonesia Data Center Provider Organization (IDPRO) to support the development of a reliable, sustainable, and globally competitive data center industry in Indonesia. IDPRO is the official industry association representing data center providers and digital infrastructure companies in Indonesia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261101556619/en/ Signing of Uptime Institute and IDPRO MOU. The goal of the collaborative agreement between the two organizations is to promote international standards and best practices in Indonesia across the data center lifecycle, strengthening infrastructure availability and operational resilience, advancing resource efficiency and sustainability, and supporting the development of a skilled industry workforce. These priorities will help raise indus
AIT Worldwide Logistics Expands Global Footprint to Oceania with Acquisition of Australia-Based Forwarder Connor Anderson International2.11.2026 05:01:00 CET | Press release
Strategic investment increases AIT’s geographic reach, high-tech logistics support capabilities Supply chain solutions leader AIT Worldwide Logistics (“AIT”) has finalized an agreement to acquire Connor Anderson International (“CAI”), a global freight forwarder based in Sydney. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261028626874/en/ Acquiring Connor Anderson International serves as the foundation for AIT's long-term expansion to serve Oceania more broadly. Founded in 1974, CAI delivers comprehensive logistics support, including sea, air and road transport, customs brokerage, warehousing, and project cargo management for customers across a wide range of industries. Notably, CAI’s long-tenured team manages a wide variety of specialized cargo while increasingly emphasizing distinctive services for technology companies serving the Australia and broader Oceania markets. The acquisition will strengthen AIT’s specialized se
MultiBank Exchange, Part of MultiBank Group, Unveils World’s Fastest Interbank Matching Engine and Digital Asset Settlement2.11.2026 03:00:00 CET | Press release
Platform connects more than 30 tier-one banks and liquidity providers, combining 400-nanosecond matching with credit services and settlement in fiat currencies and digital assets Board of Directors of MultiBank Exchange Holding formed, chaired by Naser Taher MultiBank Exchange, part of MultiBank Group, one of the world’s largest financial derivatives institutions, has announced the world’s first interbank trading platform to offer double exotic currency pairs with settlement in both fiat currencies and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261101073341/en/ MultiBank Exchange is designed to connect banks and financial institutions across the GCC, BRICS and other emerging markets with Western trading technology and global liquidity. Its objective is to enable these institutions to participate in international foreign exchange markets on an equal footing with their Western counterparts. With daily tradi
Emirati Mohammed Al Hakim Appointed Vice Chairman of MultiBank Group, Valued at US$32 Billion, and CEO of MB.io2.11.2026 03:00:00 CET | Press release
Former Crypto.com regional executive brings UAE government experience and a track record of commercial growth and partnerships with Emirates and Dubai Duty FreeAl Hakim will strengthen MultiBank Group’s global presence, lead MB.io into new markets and develop MultiBank Exchange’s institutional reach MultiBank Group, one of the world’s largest financial derivatives institutions, has appointed Mohammed Al Hakim as Vice Chairman of MultiBank Group and CEO of MB.io, who will strengthen the Group’s global presence, lead MB.io into new international markets and oversee the expansion of MultiBank Exchange. The appointment supports the Group’s ambitions across financial markets, digital assets and financial technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261101934535/en/ MultiBank Group, one of the world’s largest financial derivatives institutions, has appointed Mohammed Al Hakim as Vice Chairman of MultiBank Group and C
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom